Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion

NCT01044329 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Branch Retinal Vein Occlusion

Interventions

DRUG: Bevacizumab
DRUG: Triamcinolone Acetonide

Sponsor

Shahid Beheshti University of Medical Sciences

Collaborators

[object Object]